Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 209,920,997 papers from all fields of science
Search
Sign In
Create Free Account
HPE 101
Known as:
HPE-101
National Institutes of Health
Create Alert
Alert
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
Possibility and effectiveness of drug delivery to skin by needle-free injector.
Naoko Inoue
,
H. Todo
,
+4 authors
K. Sugibayashi
International journal of pharmaceutics
2010
Corpus ID: 25709443
2006
2006
The effect of skin permeation enhancers on the formation of porphyrins in mouse skin during topical application of the methyl ester of 5-aminolevulinic acid.
A. Bugaj
,
A. Juzeniene
,
P. Juzenas
,
V. Iani
,
L. Ma
,
J. Moan
Journal of Photochemistry and Photobiology. B…
2006
Corpus ID: 7346889
2006
2006
The effect of dimethylsulfoxide, 1-[2-(decylthio)ethyl]azacyclopentan-2-one and Labrafac(®)CC on porphyrin formation in normal mouse skin during topical application of methyl 5-aminolevulinate: A…
A. Bugaj
,
V. Iani
,
A. Juzeniene
,
P. Juzenas
,
Li-wei Ma
,
J. Moan
Photodiagnosis and Photodynamic Therapy
2006
Corpus ID: 25554956
2004
2004
Application of in Vivo Microdialysis to Transdermal Absorption of Methotrexate in Rats
K. Matsuyama
,
M. Nakashima
,
Yukiko Nakaboh
,
M. Ichikawa
,
T. Yano
,
S. Satoh
Pharmaceutical Research
2004
Corpus ID: 10795621
Microdialysis was applied to determine the in vivo transdermal absorption of methotrexate (MTX) in rats with or without a new…
Expand
1996
1996
Evaluation of In‐vivo Transdermal Absorption of Cyclosporin with Absorption Enhancer Using Intradermal Microdialysis in Rats
M. Nakashima
,
Meijun Zhao
,
+4 authors
M. Ichikawa
The Journal of pharmacy and pharmacology
1996
Corpus ID: 21766961
The purpose of this study was to evaluate the effect of absorption enhancer on in‐vivo transdermal absorption of cyclosporin…
Expand
1994
1994
In vivo microdialysis for the transdermal absorption of valproate in rats.
K. Matsuyama
,
M. Nakashima
,
M. Ichikawa
,
T. Yano
,
S. Satoh
,
S. Goto
Biological and Pharmaceutical Bulletin
1994
Corpus ID: 20720088
The suitability of sampling via microdialysis for a lipophilic drug, valproate (VPA), was evaluated by the elimination rate…
Expand
1993
1993
Further Evaluation of a New Penetration Enhancer, HPE‐101
T. Yano
,
N. Higo
,
Kazuya Fukuda
,
M. Tsuji
,
K. Noda
,
M. Otagiri
The Journal of pharmacy and pharmacology
1993
Corpus ID: 20608693
Abstract— The penetration enhancer, 1‐[2‐(decylthio)ethyl]azacyclopentan‐2‐one (HPE‐101), significantly enhanced the excretion of…
Expand
1992
1992
Inhibitory effect of prostaglandin E1 on laurate-induced peripheral vascular occlusive sequelae in rabbits: optimized topical formulation with beta-cyclodextrin derivative and penetration enhancer…
H. Adachi
,
T. Irie
,
K. Uekama
,
T. Manako
,
T. Yano
,
M. Saita
The Journal of pharmacy and pharmacology
1992
Corpus ID: 36708590
Prostaglandin E1 (PGE1) and its inclusion complexes with beta-cyclodextrin (beta-CyD) and O-carboxymethyl-O-ethyl-beta…
Expand
1992
1992
Evaluation of a new penetration enhancer 1-[2-(decylthio)ethyl]azacyclopentan-2-one (HPE-101).
T. Yano
,
N. Higo
,
K. Furukawa
,
M. Tsuji
,
K. Noda
,
M. Otagiri
Journal of Pharmacobio-Dynamics
1992
Corpus ID: 24612866
A new compound, 1-[2-(decylthio)ethyl]azacyclopentan-2-one (HPE-101) was synthesized, and its skin penetration enhancing activity…
Expand
1992
1992
Improved transdermal delivery of prostaglandin E1 through hairless mouse skin: combined use of carboxymethyl‐ethyl‐β‐cyclodextrin and penetration enhancers
K. Uekama
,
H. Adachi
,
T. Irie
,
T. Yano
,
M. Saita
,
K. Noda
The Journal of pharmacy and pharmacology
1992
Corpus ID: 43182223
Abstract— The optimal prescription of transdermal preparations of prostaglandin E1 (PGE1) for treatment of peripheral vascular…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE